Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease

Published:2017-03-24 Issue:4 Volume:32 Page:769-777
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Cheon Jae Hee¹²³

Affiliation:

1. Department of Internal Medicine and Institute of Gastroenterology; Yonsei University College of Medicine; Seoul Korea

2. Severance Biomedical Science Institute; Yonsei University College of Medicine; Seoul Korea

3. Brain Korea 21 PLUS Project for Medical Science; Yonsei University College of Medicine; Seoul Korea

Funder

Ministry of Health and Welfare, Republic of Korea

Ministry of Science, ICT & Future Planning

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13612/fullpdf

Reference70 articles.

1. Genetics of inflammatory bowel diseases: a comparison between Western and Eastern perspectives;Cheon;J. Gastroenterol. Hepatol.,2013

2. Efficacy of treatment with chimeric monoclonal antibody (infliximab) to tumor necrosis factor-alpha for Crohn's disease in Japan: evaluation by rapid turnover proteins, and radiologic and endoscopic findings;Asakura;J. Gastroenterol. Hepatol.,2001

3. Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: a Korean multicenter retrospective study;Lee;J. Gastroenterol. Hepatol.,2013

4. Efficacy and safety of treatment with infliximab in Crohn's disease-the experience of single center in Korea;Choi;Korean J. Gastroenterol.,2005

5. Long-term efficacy of infliximab maintenance therapy for perianal Crohn's disease;Uchino;World J. Gastroenterol.,2011

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023;Intestinal Research;2024-07-31

2. Anti-Inflammatory Activity of Peptides from Ruditapes philippinarum in Lipopolysaccharide-Induced RAW264.7 Cells and Mice;Foods;2024-03-14

3. Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review;World Journal of Gastroenterology;2023-08-07

4. The treatment of inflammatory bowel disease with monoclonal antibodies in Asia;Biomedicine & Pharmacotherapy;2023-01

5. Burdock ( Arctium lappa L .) leaf flavonoids rich in morin and quercetin 3‐O‐rhamnoside ameliorate lipopolysaccharide‐induced inflammation and oxidative stress in RAW264.7 cells;Food Science & Nutrition;2022-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3